Search

everythinglearnresearchcommunity

for

Search:↓

Understanding skin reactions to radiation has improved, helping to reduce injuries and prevent skin cancer.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

Caspases do more than kill cells; they also help in cell growth and disease, and targeting them could lead to new treatments.

Managing stress and nerve activity can help treat segmental vitiligo and white hair.

Dupilumab and COVID-19 can worsen or trigger psoriasis.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Lipid–polymer hybrid nanoparticles can improve genome editing delivery and outcomes.

New cytokine-targeted therapies show promise for treating alopecia areata.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

Lichen planopilaris can occur with multiple autoimmune diseases.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Photodynamic therapy can remove nonpigmented hair in mice and might work for humans.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Finasteride improves hidradenitis suppurativa but not for child-bearing women.

Effective treatments for severe alopecia areata are still lacking.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Genetic differences affect COVID-19 severity and treatment development.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Treating cystoid macular oedema in uveitis is difficult and risky.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Skin structure complexity and variability are crucial for assessing skin toxicity in safety tests.